The endometrial ablation devices market had a market value of US$ 985.8 million in 2017 and is expected to grow at a CAGR of 5.3% between 2018 and 2026. Abnormal uterine bleeding is one of the most prevalent gynecological diseases observed in the last decade and, if left untreated, may lead to a low red blood cell count and anemia. Endometrial ablation treatment is considered the most effective treatment for patients suffering from abnormal uterine bleeding. According to several research studies, the prevalence of menorrhagia ranges from 9% to 14%, specifically in research studies that measured menstrual blood loss. However, a few studies based on subjective assessment suggested that the prevalence of menorrhagia is much higher than that, in a range of 20% to 52%.
Market Synopsis
Radiofrequency endometrial ablation devices will maintain their dominance throughout the forecast period due to supportive reimbursement policies, the high preference and support received from medical practitioners, and the fact that they are cost-effective for patients from developing and underdeveloped countries. The increasing prevalence of gynecological disorders is also one of the key reasons responsible for the growth of the endometrial ablation devices market. According to the Department of Epidemiology and Preventive Medicine, a population-based survey carried out in the United States of women aged 18 to 50 years suggested that the annual prevalence rate of abdominal uterine bleeding is 53 per 1000 women.
With the rising prevalence of abnormal uterine bleeding and supportive reimbursement policies for endometrial ablation, North America was identified as the largest market.
North America dominated the overall endometrial devices market due to key factors important for driving the market's growth, such as the high prevalence of abnormal uterine bleeding, supportive reimbursement policies, high awareness related to the latest endometrial ablation devices, and the increasing number of ambulatory surgery centers. The Asia Pacific is the fastest-growing market due to factors such as the mounting prevalence of gynecological disorders due to a lack of awareness and hygiene and a huge gap in healthcare services and unmet medical needs of patients from developing countries such as India and China.
Periods of History and Forecast
The endometrial ablation devices market was examined using current market trends for the base year of 2017, and CAGRs were calculated based on future trends for the forecast period of 2018 to 2026.
Report Scope by Segments
This report covers an in-depth analysis of the endometrial ablation market, including statistical and subjective data points, along with the key market drivers, opportunities, and restraints that have positive or negative effects on the overall global market. Exclusive coverage is provided for market drivers, challenges, and opportunities for a country-level market in the respective regional segments. This report covers in-depth information associated with the global endometrial ablation devices market with segments such as types of devices, end-users, and geography. The report comprises a competitive analysis of the key players functioning in the endometrial ablation devices market that covers in-depth data related to the competitive landscape of the market and the recent strategies and products assisting or affecting the market in the near future.
The major players present in the market were analyzed based on financial information, product portfolios, recent market updates, and key market strategies. This report also comprises attractive investment propositions analyzed with the help of exhaustive geographical research based on PESTEL analysis. Key players profiled in the report include Hologic Corporation, Boston Scientific Corporation, Karl Storz GmbH & Co. KG, Minerva Surgical, Inc., Olympus Corporation, Smith & Nephew plc, The Cooper Companies, Inc., Ethicon, Inc., Medtronic plc, Richard Wolf GmbH, and AngioDynamics Inc., among others.
Key questions are answered in this report.
Which is the trending device type in the market preferred for endometrial ablation, and why?
What are the recent market strategies followed by major players and the competitive analysis specific to the endometrial ablation devices market?
Which are the major geographical markets (regions and countries) in the endometrial ablation devices market?
Which are the largest and fastest-growing endometrial ablation device types globally?
What is the competitive landscape of the endometrial devices market like, and what are the strategies of the major players in this industry?
Frequently Asked Questions:
The market for Endometrial Ablation Devices Market is expected to reach US$ 985.8 Mn by 2026.
The Endometrial Ablation Devices Market is expected to see significant CAGR growth over the coming years, at 5.3%.
The report is forecasted from 2018-2026.
The base year of this report is 2017.
Karl Storz GmbH & Co. KG, Minerva Surgical, Inc., Olympus Corporation, Smith & Nephew plc, The Cooper Companies, Inc., Ethicon, Inc., Medtronic plc, Richard Wolf GmbH, and AngioDynamics Inc. are some of the major players in the global market.
